Metabolism Of Micro-organism Enhanced (e.g., Growth Enhancement Or Increased Production Of Microbial Product) Patents (Class 435/173.8)
-
Publication number: 20110189748Abstract: A method of increasing the rate of growth, useful product production, or protein expression of a microorganism includes the step of exposing the microorganism to ultrasound having a frequency greater than about 1 MHz.Type: ApplicationFiled: August 26, 2009Publication date: August 4, 2011Applicant: INTELLIGENTNANO INC.Inventors: Jie Chen, James Xing, Woon T. Ang
-
Patent number: 7981611Abstract: Methods and devices are described for the regulation of Fibroblastic Growth Factor-2 mRNA and/or FGF-2 protein in bone cells and other tissues via capacitive coupling or inductive coupling of specific and selective electric and/or electromagnetic fields to the bone cells or other tissues, where the specific and selective fields are generated by application of specific and selective signals to electrodes or one or more coils or other field generating device disposed with respect to the bone cells or other tissues so as to facilitate the treatment of diseased or injured bone and other tissues. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein.Type: GrantFiled: February 8, 2008Date of Patent: July 19, 2011Assignee: The Trustees Of The University Of PennsylvaniaInventor: Carl T. Brighton
-
Publication number: 20110171712Abstract: The invention relates to a new approach to constructing cellular aggregates in vitro and their use in methods for producing 3D-tissue constructs in a modular way. In particular, the invention is directed to a method for in vitro producing a tissue construct comprising: a) combining living cells to form supracellular aggregates using spatial confinement; b) combining two or more of the supracellular aggregates in a mold or on a biomaterial; c) applying conditions that induce self-assembly within the combined supracellular aggregates to obtain the tissue construct; and d) applying conditions that induce tissue morphogenesis in the tissue construct.Type: ApplicationFiled: June 22, 2009Publication date: July 14, 2011Applicant: UNIVERSITEIT TWENTEInventors: Nicolas Clément Rivron, Jeroen Rouwkema, Roman Truckenmuller, Séverine Le Gac, Clemens Antoni Blitterswijk, Erik Jacob Vrij
-
Publication number: 20110159562Abstract: According to one aspect and example, a method for facilitating cellular interactions in biological tissue provides controllable activation of a selected type of stem cell among a plurality of cell types present in the tissue. The method includes various steps including the introduction of a microbial opsin into a region of the tissue that includes a selected type of stem cell, by expressing the microbial opsin in the stem cell. A light source is then introduced near the stem cell, and the light source is used to controllably activate the light source to direct pulses of illumination from the light source to the selected type of stem cell, for selectively controlling the growth and development of the stem cell in a manner that is independent of the growth and development of the other types of cells.Type: ApplicationFiled: June 17, 2009Publication date: June 30, 2011Inventors: Karl Deisseroth, Albrecht Stroh, M. Bret Schneider, Raag D. Airan
-
Publication number: 20110097605Abstract: A yeast biofilm microbial fuel cell has anode and cathode chambers, each containing an electrolyte medium, separated by a proton conducting membrane. A baker's yeast biofilm is induced to form on the anode under electrical poising. A method of making the MFC includes adding baker's yeast and yeast nutrient fuel source to the anode solution, connecting a resistor across the anode and cathode to enable current flow through the resistor for a selected time for poising the anode and formation of the anodic yeast biofilm, replacing the anode solution with a fresh quantity of yeast-free solution, adding fuel source to the solution, and continuing to run the MFC for a selected time under resistance. The steps of replacing the anode solution, adding fuel source and running the cell under load are repeated until the baker's yeast has formed a suitable anodic biofilm.Type: ApplicationFiled: October 26, 2009Publication date: April 28, 2011Applicant: TELEDYNE SCIENTIFIC & IMAGING, LLCInventors: Rahul Ganguli, Vivek Mehrotra
-
Publication number: 20110092726Abstract: Described are methods of cultivating autotrophic microorganisms, particularly microalgae or diatoms, in a bioreactor by entraining a culture of the microorganisms in a tenuous, gelated, thixotrophic carrier medium having nutrients therefor and moving the medium along a passage at a sufficiently slow speed to enable laminar flow which in cross section is closed and which has transparent walls through which the culture is irradiated to enable photosynthesis. The method includes effecting convective turnover of the culture and medium as they flow along the passage by differentially heating the medium laterally relative to the flow direction so as to produce a generally helical flow of the culture and medium. Also described are processing methods, both physical and chemical, performed underground e.g.Type: ApplicationFiled: December 10, 2010Publication date: April 21, 2011Inventor: William Severn Clarke
-
Publication number: 20110087157Abstract: Stem cells are proliferated with the application of acoustic pressure waves, including cambium cells of periosteum treated in-vivo with acoustic pressure waves. Following harvesting and viability assessment of in-vivo or in-vitro proliferated stem cells, acoustic pressure waves are applied to enhance in-vivo or in-vitro differentiation either before or after implantation of the stems cells to an organism. Acoustic pressure waves also stimulate an implantation site to enhance viability and to grow desired tissue.Type: ApplicationFiled: October 8, 2010Publication date: April 14, 2011Inventors: Iulian Cioanta, Christopher M. Cashman
-
Patent number: 7923238Abstract: Systems, methods and apparatus provide flexible and efficient high throughput electroporation systems. An electrical pulse may be transmitted to any number of channels of a multi-channel sample plate. Drivers can provide the selection of which channels to transmit the electrical pulse. To provide efficient transitions between electrical pulses, discharge circuits provide efficient means achieve a desired voltage.Type: GrantFiled: December 6, 2006Date of Patent: April 12, 2011Assignee: Bio-Rad Laboratories, Inc.Inventor: Charles W. Ragsdale
-
Patent number: 7892799Abstract: A method for in vivo, ex vivo and in vitro regeneration of cartilage, collagen and bone remodeling by intermittently applied hydrostatic pressure consisting of repeated periods of applied hydrostatic pressure followed and interrupted by periods of recovery. The intermittent hydrostatic pressure is applied at physiological levels 5-10 MPA for an interval of 4 hours followed by a recovery period up to about 20 hours. The interval loading results in the selective inhibition of matrix degrading enzymes, pro-inflammatory cytokines and chemokines that attract inflammatory cells into the joint cavity and in selective decrease of gene expression of growth factors that are inhibitory to type II collagen expression.Type: GrantFiled: August 30, 2007Date of Patent: February 22, 2011Assignees: The Board of Trustees of the Leland Stanford Junior University, The United States of America as represented by the Department of Veterans AffairsInventors: Robert Lane Smith, Dennis R. Carter, David J. Schurman
-
Publication number: 20110034753Abstract: The present invention provides a method of selectively activating and/or targeting stem cells which enables the cells to then be manipulated mechanically in a remote manner wherein the method comprises magnetically manipulating a stem cell in vivo or in vitro by the association of a magnetisable particle within the stem cell.Type: ApplicationFiled: December 8, 2004Publication date: February 10, 2011Inventors: Jon Dobson, Alicia El Haj
-
Publication number: 20100311138Abstract: A method for producing ethanol by fermentation includes the preparation of a starter culture, inoculation of a mash with the starter culture, fermentation of the mash, and recovery of ethanol from the mash. The starter culture includes a tallow base with Chinese tallow tree parts and water which are inoculated with micro-organisms, where the micro-organisms include yeast. The micro-organisms are grown in the tallow base, and used to inoculate the mash. The mash is then fermented, and ethanol is recovered from the mash.Type: ApplicationFiled: June 8, 2009Publication date: December 9, 2010Inventor: Randall Padgett
-
Publication number: 20100291045Abstract: Dynamic vibrational methods and devices for inducing differentiation of stem cells into vocal fold fibroblast-like cells or for generating vocal fold-like tissue from cultured cells. Also provided are matrices providing sustained release of growth factors, and bioreactors generating and delivering a high frequency vibration with in-plane shear stress to cultured cells.Type: ApplicationFiled: May 17, 2010Publication date: November 18, 2010Applicant: University of DelawareInventors: Xinqiao Jia, Mingde Jia, Amit K. Jha, Alexandra J.E. Farran, Zhixiang Tong
-
Publication number: 20100285558Abstract: A method for high-throughput micro-cell culture with mechanical stimulation includes providing cells on a membrane, supplying a culture medium to the cells, and vibrating the membrane by exerting and varying a fluid pressure on the membrane such that the cells are mechanically stimulated through the membrane. An apparatus for high-throughput micro-cell culture with mechanical stimulation includes a cell culture vessel and a fluid pressure supply unit. The cell culture vessel has the membrane, a culture medium chamber, and a pressure chamber. The fluid pressure supply unit is connected fluidly to the pressure chamber, and has a fluid pressure supply device and a control device. The membrane vibrates when the fluid pressure in the pressure chamber is varied. The apparatus provides mechanical stimulation to the cultured cells in a controllable manner.Type: ApplicationFiled: May 8, 2009Publication date: November 11, 2010Inventors: Min-Hsien Wu, Wei-Chung Pan, Chun-Yen Kuo
-
Publication number: 20100284978Abstract: Stem cells from human sources can have a variety of useful applications in disease treatment and biotechnology. More particularly the umbilical cord matrix cell cultures of the invention have a variety of totipotent, pluripotent, or multipotent cells for a variety of end uses from a non-controversial, universally available, species-specific source. The technology can have application to any amniotic animal, including agricultural and laboratory animals and humans. The invention relates to isolating the stem cells, culturing the stem cells, maintaining the stem cells, transforming the stem cells into useful cell types using genetic or other transformation technologies, stem cell and tissue banking and using untransformed or transformed cells in disease treatment.Type: ApplicationFiled: May 4, 2010Publication date: November 11, 2010Applicant: KANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInventors: Mark L. Weiss, Deryl L. Troyer, Duane Davis, Kathy E. Mitchell
-
Publication number: 20100239544Abstract: Methods of modifying stem cells and compositions of modified stem cells, in particular mesenchymal stem cells, using electric or electromagnetic fields. In various embodiments, the present invention's methods are for the treatment of a human or other mammal subject in need thereof, comprising providing an in vitro culture comprising mesenchymal stem cells, administering an electric stimulation to the in vitro culture, and implanting the mesenchymal stem cells into the subject. Methods also include treatment of a human or other mammal subject, comprising implanting mesenchymal stem cells into the subject, and administering an electric stimulation to the mesenchymal stem cells in situ. Other embodiments include methods of administering electric stimulation in conjunction with growth factors to stem cells.Type: ApplicationFiled: June 1, 2010Publication date: September 23, 2010Applicant: EBI, LLCInventor: Bruce SIMON
-
APPARATUS AND METHOD FOR GROWING PLANTS, A BIOMASS, OR MICRORGANISMS IN WATER THROUGH PHOTOSYNTHESIS
Publication number: 20100221806Abstract: Presented is an apparatus for growing plants, a biomass, or a microorganism through photosynthesis. The apparatus includes a hollow tube-like structure of flexible transparent material having a first end, a second end, and a middle section, and defining an interior for receiving, through one of the ends, an aqueous solution, a gas comprising carbon dioxide, and at least one of seeds of the plants, a sample of the biomass, and a sample of the microorganism to be grown. The apparatus further includes a support connected to the first or second end of the tube-like structure for positioning the first or second end at a height above the middle section, and an agitator connected to the tube-like structure to impart motion to the aqueous solution in the interior such that when the tube-like structure is exposed to electromagnetic radiation, growth of the plants, biomass, or microorganism occurs through photosynthesis.Type: ApplicationFiled: August 15, 2008Publication date: September 2, 2010Inventors: Chaim Lieberman, Israel Horowitz -
Publication number: 20100216207Abstract: An apparatus is disclosed for growing algae by ionizing radiation. The apparatus includes a container for containing medium for the growth of algae, a filter disposed in the container, a 3-dimensional rack disposed in the container, an adherent element wound on the 3-dimension rack so that spores of the algae can be planted in the adherent element, a radiation element disposed in the container for irradiating the spores and a timepiece connected to the radiation element.Type: ApplicationFiled: October 30, 2007Publication date: August 26, 2010Applicant: ATOMIC ENERGY COUNCIL - INSTITUTE OF NUCLEAR ENERGY RESEARCHInventors: Yean-Chang Chen, Kuan-Yin Chen, Chia-Chieh Chen, Bin Lin, Hsueh-Hsuan Liu, Meng-Chou Lee, Wuu-Jyh Lin, Ying-Kai Fu, Lie-Hang Shen, Wen-Song Hwang, Ming-Chao Kuo, Wei-Hsi Chen, Te-Hsing Wu
-
Publication number: 20100204753Abstract: A cell construct includes cells in contact with at least one basement membrane and/or at least one stroma, wherein the basement membrane or stroma contains elements for applying mechanical stimulation on the cells. The process of manufacture of the cell construct and its use, as well as a device, an implant and processes for the mechanical stimulation of cells in vitro and in vivo are also described.Type: ApplicationFiled: April 29, 2008Publication date: August 12, 2010Inventor: Remy Brossel
-
Publication number: 20100203143Abstract: The present invention relates to signaling mechanisms that transduce magnetic inputs into physiological cellular outputs. More particularly, the present invention relates to systems and methods for non-invasively controlling cellular signaling functions and behaviors by harnessing receptor-mediated and intracellular molecular-mediated signal transduction using nanomagnetic cellular switches.Type: ApplicationFiled: April 9, 2008Publication date: August 12, 2010Applicant: CHILDREN'S MEDICAL CENTER CORPORATIONInventors: Donald E. Ingber, Robert J. Mannix, Sanjay Kumar
-
Publication number: 20100178680Abstract: A rotatable perfused time varying electromagnetic force bioreactor with a rotatable perfusable culture chamber and a time varying electromagnetic force source operatively connected to the rotatable perfusable culture chamber. In use, the rotatable perfused time varying electromagnetic force bioreactor supplies a time varying electromagnetic force to the rotatable perfusable culture chamber of the rotatable perfused time varying electromagnetic force bioreactor to expand cells contained therein.Type: ApplicationFiled: June 26, 2006Publication date: July 15, 2010Applicants: REGENETECH, INC., NASAInventors: Thomas J. Goodwin, Clayton R. Parker
-
Patent number: 7754447Abstract: The present invention provides a method for controlling the partitioning of a recombinant protein between the supernatant and the periplasm in E. coli host cell cultures wherein expression of the recombinant protein by said cells is under the control of an inducible system, which method comprises: a) providing an E. coli host cell culture b) changing the growth rate of the E. coli host cells c) inducing expression of the recombinant protein wherein steps (b) and (c) can be performed in any order or simultaneously; and subsequently d) determining the yield of recombinant protein in the culture supernatant and the E. coli host cell periplasm e) comparing the yield determined in step (d) with the yield determined when at least one other growth rate has been used in step (b) f) selecting a growth rate from the comparison made in step (e) in which the partitioning of the recombinant protein between the supernatant and the periplasm is most suited to the primary recovery of the recombinant protein.Type: GrantFiled: September 2, 2004Date of Patent: July 13, 2010Assignee: UCB Pharma S.A.Inventors: David John Glover, Mukesh Sehdev, Dominic Gambier Reeks
-
Publication number: 20100144004Abstract: A cell culture system for directing growth of cells is provided. The cell culture system includes a substrate, a culture layer and a culture medium. The culture layer is located on the substrate. The culture layer includes at least one carbon nanotube film including a plurality of carbon nanotubes orientated primarily along a same direction. The culture medium covers the culture layer and includes at least one growth factor.Type: ApplicationFiled: August 7, 2009Publication date: June 10, 2010Applicants: Tsinghua University, HON HAI Precision Industry CO., LTD.Inventors: Cheng Zhong, Li Fan
-
Patent number: 7732175Abstract: The invention relates to a method for treating biomaterial using at least one electrical field generated by a first voltage pulse which is terminated once the value for an electrical parameter has exceeded or dropped below a preset limit. After the first voltage pulse has been terminated, it is continued by an additional voltage pulse. The invention also relates to a circuit arrangement comprising at least one storage device for electrical charges to generate at least one voltage pulse by selectively discharging the storage device, and at least one control unit for controlling the discharge. The present invention provides a controller for monitoring the chronological progression of the voltage pulse. This controller controls at least one continuation of discharge after termination.Type: GrantFiled: June 14, 2005Date of Patent: June 8, 2010Assignee: Lonza Cologne AGInventor: Herbert Mueller-Hartmann
-
Publication number: 20100120626Abstract: Provided herein are apparatus and methods relating to the development of instrumentation for high throughput network electrophysiology and cellular analysis. More specifically, provided herein are multiwell microelectrode arrays (MEAs) and methods for the development of such an apparatus in an inexpensive fashion with a flexible, ANSI/SBS-compliant (American National Standards Institute/Society for Biomolecular Screening) format. Microelectrode arrays are a grid of tightly spaced microelectrodes useful for stimulating and sensing electrically active cells, networks and tissue. The techniques described herein relate to the use of microfabrication in combination with certain large-area processes that have been employed to achieve multiwell MEAs in ANSI/SBS-compliant culture well formats, which are also transparent for inverted/backside microscopy compatibility.Type: ApplicationFiled: November 10, 2009Publication date: May 13, 2010Inventors: James Ross, Edgar A. Brown, Swaminathan Rajaraman, Mark G. Allen, Bruce Wheeler
-
Patent number: 7709260Abstract: The invention relates to a method for preparing closed bacterial ghosts by way of specific interactions between partners of a bioaffinity binding pair, and to the bacterial ghosts which can be obtained in this way. Active compounds can be packed into the closed bacterial ghosts. The closed ghosts can be employed in medicine, in the agricultural sphere and in biotechnology.Type: GrantFiled: August 5, 2004Date of Patent: May 4, 2010Inventor: Werner Lubitz
-
Publication number: 20100094383Abstract: An irradiation device by modulated photonic energy radiation comprising a photonic emitter module (11) emitting nanometric-frequencies. The emitter module is connected to modulating means performing a first chopping at low frequency (LF) and a second chopping at radiofrequency (RF) to obtain a sequence of pulses at low frequency (LF) chopped at radiofrequency (RF).Type: ApplicationFiled: March 20, 2008Publication date: April 15, 2010Inventors: Jean-Pierre Breda, Eric D. Cordemans De Meulenaer
-
Publication number: 20100055757Abstract: Disclosed are methods for expanding stem cells that use a unique combination of environmental factors and cell culture conditions to produce stem cells having enhanced proliferation and differentiation characteristics. Also disclosed are methods for enhancing the engraftment and/or migratory potential of stem cells for therapeutic uses. Stem cells having unique proliferation, differentiation, migratory and engraftment characteristics are also disclosed.Type: ApplicationFiled: March 24, 2009Publication date: March 4, 2010Inventors: CHIH-MIN LIN, Alex Wharazi
-
Publication number: 20090328258Abstract: This present invention provides methods of enhancing the growth of a microorganism or plant by increasing its melanin content and exposing it to radiation, and methods of using melanized microorganisms to contain or exclude radiation.Type: ApplicationFiled: April 2, 2007Publication date: December 31, 2009Inventors: Ekaterina Dadachova, Ruth Bryan, Arturo Casadevall
-
Publication number: 20090317885Abstract: Disclosed are nitric oxide delivery agents and methods of their use, more specifically to photoactive compounds, which are able to perform targeted delivery of nitric oxide in vitro and in vivo and are useful for medicinal applications including, but not limited, to blood pressure regulation and cancer treatment.Type: ApplicationFiled: August 13, 2009Publication date: December 24, 2009Inventor: Pradip K. Mascharak
-
Publication number: 20090276019Abstract: Disclosed herein is a method comprising repetitive electromagnetic field shock to at least one living cell, wherein the repetitive electromagnetic field shock improves HSF1 and/or HSR function, and producing delaying and reversal of aging and age related diseases. Also disclosed herein is an apparatus adapted to deliver repetitive electromagnetic field shock to at least one living cell, wherein the repetitive electromagnetic field shock improves HSF1 and HSR function.Type: ApplicationFiled: March 19, 2009Publication date: November 5, 2009Applicant: The Board of Trustees of the University of IllinoisInventors: Felipe Pablo Perez, Donald A. Jurivich, Jorge Javier Morisaki, Ximing Zhou
-
Publication number: 20090233342Abstract: The invention relates to functional heterologous expression of proteorhodopsin photosystems in cells and the use of such proteorhodopsin photosystems in methods for increasing energy content of a cell, redirecting carbon flow in a cell, increasing a production of a carbon-based compound in a cell and increasing production of a metabolite in a cell.Type: ApplicationFiled: August 22, 2008Publication date: September 17, 2009Inventors: Asuncion Martinez, Edward F. Delong
-
Publication number: 20090215123Abstract: The present invention relates to a method for production of continuous cell lines comprising providing living cells of an animal or a human, irradiating said cells with UV light, proliferating said cells and selecting multiplying cells as cells of a continuous cell line.Type: ApplicationFiled: February 20, 2009Publication date: August 27, 2009Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.Inventors: Manfred Reiter, Wolfgang Mundt, Simone Feigl, Simone Von Fircks
-
Patent number: 7572623Abstract: The present invention involves methods and devices which enable discrete objects having a conducting inner core, surrounded by a dielectric membrane to be selectively inactivated by electric fields via irreversible breakdown of their dielectric membrane. One important application of the invention is in the selection, purification, and/or purging of desired or undesired biological cells from cell suspensions. According to the invention, electric fields can be utilized to selectively inactivate and render non-viable particular subpopulations of cells in a suspension, while not adversely affecting other desired subpopulations. According to the inventive methods, the cells can be selected on the basis of intrinsic or induced differences in a characteristic electroporation threshold, which can depend, for example, on a difference in cell size and/or critical dielectric membrane breakdown voltage.Type: GrantFiled: April 23, 2003Date of Patent: August 11, 2009Inventors: Joseph Mangano, Henry Eppich
-
Patent number: 7560269Abstract: The present invention includes devices, systems, and methods for assaying cells using cell-substrate impedance monitoring. In one aspect, the invention provides cell-substrate impedance monitoring devices that comprise electrode arrays on a nonconducting substrate, in which each of the arrays has an approximately uniform electrode resistance across the entire array. In another aspect, the invention provides cell-substrate monitoring systems comprising one or more cell-substrate monitoring devices comprising multiple wells each having an electrode array, an impedance analyzer, a device station that connects arrays of individual wells to the impedance analyzer, and software for controlling the device station and impedance analyzer. In another aspect, the invention provides cellular assays that use impedance monitoring to detect changes in cell behavior or state. The methods can be used to test the effects of compounds on cells, such as in cytotoxicity assays.Type: GrantFiled: February 9, 2005Date of Patent: July 14, 2009Assignee: ACEA Biosciences, Inc.Inventors: Xiaobo Wang, Xiao Xu, Yama Abassi
-
Publication number: 20090170178Abstract: It is an object of the present invention to provide an electrical stimulating device for efficiently providing direct electrical stimulation to a large number of nerve cells in vitro without causing any injuries to such cells. The present invention provides a cell stimulating device which comprises: a first electrode serving as a positive or negative electrode that extends from one side of a culture vessel that is used for accommodating cultured cells to a point at which the first electrode is not in contact with the cultured cells or is in contact with the surfaces of the cultured cells; and a second electrode serving as a negative or positive electrode that extends from the other side of the culture vessel to a point at which the second electrode is not in contact with the cultured cells or is in contact with the surfaces of the cultured cells, wherein an electric field for stimulating cells is formed via the first electrode and the second electrode.Type: ApplicationFiled: April 22, 2004Publication date: July 2, 2009Applicant: RIKENInventors: Miwako Ozaki, Kouichi Itoh
-
Publication number: 20090117636Abstract: Disclosed are a method and an apparatus for accelerating the growth of E. coli by applying an electric field with a frequency in the range from 1 kHz to 1 MHz. The present invention is applicable to the enhancement of production of heterologous recombinant proteins and metabolites produced by E. coli in such fields as new drug development or research.Type: ApplicationFiled: February 8, 2008Publication date: May 7, 2009Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: MinSun KIM, Jeongje PARK
-
Publication number: 20090093037Abstract: The method and apparatus for accelerating growth of lactic acid bacteria, which apply an electric field to the lactic acid bacteria using an electric field in a frequency band of 1 kHz to 1 MHz, can be applied to all lactic acid bacteria used in home and industries to accelerate the growth of them and can be used to increase the number of the lactic acid bacteria and the production of all metabolites (for example, lactic acid and carbon dioxide) of the lactic acid bacteria. The invention increases the lactic acid bacteria and the production of the metabolites of the lactic acid bacteria, thereby activating the beneficial fermentation action of the processed foods such as fermented milk, lactic acid bacteria-containing beverage, toenjang or salted foods (kimchi or pickle and the like).Type: ApplicationFiled: February 13, 2008Publication date: April 9, 2009Applicant: SAMSUNG ELECTRONICS, CO., LTD.Inventors: MinSun KIM, JEONGJE PARK, JAECHAN PARK, KYUNGIL CHO
-
Publication number: 20090081752Abstract: A bioreactor, kit, a method of using the device to promoting growing and/or culture of a cell, and a method for regenerating and/or improving the function of mammalian cells. The bioreactor includes a controlling circuit coupled to magnetic field emitter that emits relatively steep and short-lived magnetic field pulses during these an active ephemeral period. The bioreactor also provides a relatively long-term inactive phase in which no magnetic field pulses are imposed. The kit includes the unassembled components of the bioreactor. The method of using the bioreactor and of regenerating and/or improving the function of mammalian cells includes the step of applying a time variant magnetic field through the cell to promote growing and/or culturing, and then introducing the cells to a mammal to regenerate cells.Type: ApplicationFiled: September 24, 2007Publication date: March 26, 2009Inventors: Robert G. DENNIS, David A. WOLF, Donnie RUDD
-
Patent number: 7501232Abstract: The invention relates to a method for the non-invasive selection of single living cells under gentle conditions from mixtures of cells or cell cultures with respect to a specific production performance. To this end, the concentration of substances produced by the individual cells which become enriched at the cell membrane, such as reporter gene products (GFP) or specifically secreted products, such as antibodies, is determined by fluorescence-microscopic detection methods.Type: GrantFiled: May 12, 2004Date of Patent: March 10, 2009Assignee: Probiogen AGInventors: Uwe Marx, Christian D. Demmler, Christoph Giese
-
Publication number: 20090035835Abstract: The invention relates to biotechnology, in particular to methods and means of physical action on biological structures of photosynthesing microorganisms, phototrophic algae in particular. The invention can be used in pharmaceutical, cosmetic and foodstuff industries, as well as for obtaining biofuel from algae In the process of the method implementation radiation of cultivated solution of photosynthesizing microorganisms/phototrophical algae is carried out by the action of electromagnetic waves of mm range and low intensity. Stimulation of increasing photosynthesizing microorganisms/phototrophical algae biomass and biomass of their pigments (excretions) is obtained with industrial production as a result of the resonance effect which is caused by the interaction of electromagnetic wave and biological cell.Type: ApplicationFiled: August 4, 2008Publication date: February 5, 2009Inventor: Vladimir Slavin
-
Patent number: 7470533Abstract: A device for detecting cells and/or molecules on an electrode surface is disclosed. The device detects cells and/or molecules through measurement of impedence changes resulting from the cells and/or molecules. A disclosed embodiment of the device includes a substrate having two opposing ends along a longitudinal axis. A plurality of electrode arrays are positioned on the substrate. Each electrode array includes at least two electrodes, and each electrode is separated from at least one adjacent electrode in the electrode array by an expanse of non-conductive material. The electrode has a width at its widest point of more than about 1.5 and less than about 10 times the width of the expanse of non-conductive material. The device also includes electrically conductive traces extending substantially longitudinally to one of the two opposing ends of the substrate without intersecting another trace. Each trace is in electrical communication with at least one of the electrode arrays.Type: GrantFiled: November 10, 2003Date of Patent: December 30, 2008Assignee: ACEA BiosciencesInventors: Xiao Xu, Xiaobo Wang
-
Patent number: 7468264Abstract: A method of determining the voltage and current output required for the application of specific and selective electric and electromagnetic signals to diseased articular cartilage in the treatment of osteoarthritis, cartilage defects due to trauma or sports injury, or used as an adjunct with other therapies (cell transplantation, tissue-engineered scaffolds, growth factors, etc.) for treating cartilage defects in the human knee joint and a device for delivering such signals to a patient's knee. An analytical model of the human knee is developed whereby the total tissue volume in the human knee may be determined for comparison to the total tissue volume of the diseased tissue in the animal model using electric field and current density histograms.Type: GrantFiled: April 4, 2006Date of Patent: December 23, 2008Assignee: The Trustees Of The University Of PennsylvaniaInventors: Carl T. Brighton, Solomon R. Pollack
-
Patent number: 7468263Abstract: Methods and apparatus for controlling biological functions with mechanical vibration are provided. Stimulation is applied to cells of one of an organism, bacteria or virus by mechanical vibration. The biological function comprises biological functions relating to cell growth. The biological functions relating to cell growth may include at least one of cell cultivation, cell proliferation, cell fusion, and cell differentiation.Type: GrantFiled: February 28, 2005Date of Patent: December 23, 2008Assignee: Miwatec Co., Ltd.Inventors: Akio Kishida, Tsutomu Furuzono, Kozo Miyazaki, Toru Masuzawa
-
Patent number: 7468150Abstract: A conductive polymer of polyaniline (PANi), tetracyanoquinodimethane (TCNQ) and a transferrin family member. The conductive polymer can be used in conductometric assays, including biosensor devices. One particular transferrin family member provided in the polymer is lactoferrin.Type: GrantFiled: September 22, 2006Date of Patent: December 23, 2008Assignee: Board of Trustees of Michigan State UniversityInventors: Evangelyn C. Alocilja, John C. Zhou
-
Regulation of genes via application of specific and selective electrical and electromagnetic signals
Patent number: 7465566Abstract: Methods and devices for the regulation of gene expression by cells via the application of fields generated by specific and selective electric and electromagnetic signals so as to target diseased or injured tissue for treatment. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased tissue that include providing specific and selective electric and electromagnetic signals and exposing tissue to the fields generated by the signals so as to regulate gene expression. In particular, methods and devices are provided for the targeted treatment of bone defects, osteoarthritis, osteoporosis, cancer, and other disease states.Type: GrantFiled: February 22, 2001Date of Patent: December 16, 2008Assignee: The Trustees of the University of PennsylvaniaInventors: Carl T. Brighton, Solomon R. Pollack -
Patent number: 7465546Abstract: Methods and devices are described for the regulation of Transforming Growth actor (TGF)-?1, ?2, and/or ?3 protein gene expression in bone cells and other tissues via the capacitive coupling or inductive coupling of specific and selective electric fields to the bone cells or other tissues, where the specific and selective electric fields are generated by application of specific and selective electric and electromagnetic signals to electrodes or one or more coils or other field generating device disposed with respect to the bone cells or other tissues so as to facilitate the treatment of diseased or injured bone and other tissues. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein.Type: GrantFiled: May 31, 2006Date of Patent: December 16, 2008Assignee: The Trustees of The University of PennsylvaniaInventor: Carl T. Brighton
-
Publication number: 20080299086Abstract: The object of the present invention is to provide a method of preparing excellent cultured muscle cells having high metabolic capacity and insulin responsiveness, and further provide a method for the measurement of sensitive metabolic capacity using the cells. Moreover, its purpose is to provide a culture system/culture apparatus that can smoothly translocate such highly advanced cultured muscle cells intact to activity evaluation systems of a number of drugs. Moreover, the object of the present invention is to provide cultured muscle cells that are very suitable for measurement of the membrane-translocation activity of GLUT4 in an extraneous stimulus-dependent manner such as insulin, etc., and to provide a method for the measurement of the membrane-translocation activity of GLUT4 using the cells.Type: ApplicationFiled: September 21, 2006Publication date: December 4, 2008Applicant: TOHOKU UNIVERSITYInventors: Makoto Kanzaki, Taku Nedachi, Hideaki Fujita
-
Publication number: 20080248489Abstract: The present invention concerns a novel means by which specific chosen reactions can be accelerated through the use of a new type of artificial enzyme. The invention allows specific reactions to occur at an accelerated rate, even in the presence of other non-chosen molecules, which may be very similar in structure to the chosen reactant. The reactions may be stoichiometric or catalytic.Type: ApplicationFiled: March 31, 2008Publication date: October 9, 2008Inventor: Mark Martin
-
Patent number: 7429471Abstract: Methods and devices for the regulation of matrix metalloproteinase gene expression in cartilage cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased cartilage tissue that include generating specific and selective electric and electromagnetic signals that generate fields optimized for reduction of matrix metalloproteinase gene expression and exposing cartilage tissue to the fields generated by specific and selective signals so as to regulate matrix metalloproteinase gene expression in such cartilage tissue.Type: GrantFiled: June 13, 2003Date of Patent: September 30, 2008Assignee: The Trustees of the University of PennsylvaniaInventor: Carl T. Brighton
-
Patent number: RE41391Abstract: Methods and devices for the regulation of type II collagen gene expression in cartilage cells via the application of specific and selective fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased cartilage tissue that include generating specific and selective electric and electromagnetic signals that generate specific and selective fields optimized for type II collagen gene expression and exposing cartilage tissue to the specific and selective fields generated by specific and selective signals so as to regulate type II collagen gene expression in such cartilage tissue.Type: GrantFiled: July 19, 2007Date of Patent: June 22, 2010Assignee: The Trustees of the University of PennsylvaniaInventor: Carl T. Brighton